Establishing Fully-Automated Fundus-Controlled Dark Adaptometry: A Validation and Retest-Reliability Study.

"the data are available at zenodo ( https://doi org/10 5281/zenodo 10219425 )."

"the dark adaptation testing software and a manual are available as an r package ( https://github com/maximilianpfau/darkopi [gnu gpl version 3 license]).; the software is available at: https://github com/maximilianpfau/darkest (gnu gpl version 3 license)."

"Disclosure: J.M. Oertli, None; K. Pfau, Daiichi Sankyo (C); H.P.N. Scholl, Swiss National Science Foundation (#310030_201165) (F), the Wellcome Trust (PINNACLE study) (F), and the Foundation Fighting Blindness Clinical Research Institute (ProgStar study) (F), Astellas Pharma Global Development, Inc./Astellas Institute for Regenerative Medicine (S), Boehringer Ingelheim Pharma GmbH & Co (S), Gyroscope Therapeutics Ltd. (S), Janssen Research & Development, LLC (Johnson & Johnson) (S), Novartis Pharma AG (CORE) (S), Okuvision GmbH (S), and Third Rock Ventures, LLC (S), Gerson Lehrman Group (C), Guidepoint Global, LLC (C), and Tenpoint Therapeutics Limited (C), Data Monitoring and Safety Board/Committee of Belite Bio (CT2019-CTN-04690-1), ReNeuron Group Plc/Ora Inc. (NCT02464436), F. Hoffmann-La Roche Ltd (VELODROME trial, NCT04657289; DIAGRID trial, NCT05126966), and member of the Steering Committee of Novo Nordisk (FOCUS trial; NCT03811561) (N); B.G. Jeffrey, None; M. Pfau, Novartis (R), Janssen Pharmaceutica (C), Apellis (F, C)"

"Funded by a grant of the foundation: Pro sanandis oculis, Stiftung der Basler Kantonalbank zu Gunsten des Augenspitals in Basel (awarded to M.P.), and by a Retina Suisse doctoral thesis grant (awarded to J.O.)."